Enrique
Bernal Morell
Profesor Contratado Doctor Tipo a (Vinculado)
Queen Mary University of London
Londres, Reino UnidoPublications en collaboration avec des chercheurs de Queen Mary University of London (6)
2021
-
Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study
The Lancet HIV, Vol. 8, Núm. 4, pp. e185-e196
-
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
Pulmonology, Vol. 27, Núm. 5, pp. 403-412
2020
-
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network
International Journal of Infectious Diseases, Vol. 92, pp. S15-S25
2019
-
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study
International Journal of Infectious Diseases, Vol. 83, pp. 72-76
-
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report
European Respiratory Journal, Vol. 54, Núm. 6
2014
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473